Laird Norton Wetherby Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,623
Closed -$248K – 937
2021
Q1
$248K Sell
1,623
-15
-0.9% -$2.27K 0.02% 681
2020
Q4
$211K Buy
+1,638
New +$188K 0.01% 802

Other funds holding GH

Laird Norton Wetherby Wealth Management's GH Position: Q2 2021 in Review

Laird Norton Wetherby Wealth Management sold out of Guardant Health (GH) in Q2 2021, closing a stake of 1,623 shares — an estimated $248K sold.

Laird Norton Wetherby Wealth Management first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $248K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Laird Norton Wetherby Wealth Management reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 1,623 Guardant Health shares in Q2 2021, an estimated $248K.
  • Laird Norton Wetherby Wealth Management first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
  • Laird Norton Wetherby Wealth Management's Guardant Health position peaked at $248K in Q1 2021.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2021, filed 16 Aug 2021.